Patent · US Active

Chiral compounds substituted with phosphonic acid ester functions or phosphonic acid functions

US9951093B2 · kind B2 · utility

0Cited by

2References

14Claims

0Family size

Assignee

UGISense AG · DE

Inventors

Thomas Lindhorst · Munich, DE
Birgit Werner · Innsbruck, AT
Holger Bock · Munich, DE

Key dates

Filing date	Jun 19, 2012
Grant date	Apr 24, 2018
Priority date	—
Expiry date	Dec 29, 2032

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02P20/55
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to novel compounds that contain PNA units substituted with phosphonic acid ester functions or phosphonic acid functions, and have at least one chiral center. The compounds may be used for the treatment of viral diseases, such as AIDS.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.